Literature DB >> 19768771

Determinants of cognitive impairment in elderly myasthenia gravis patients.

Camillo Marra1, Francesca Marsili, Davide Quaranta, Amelia Evoli.   

Abstract

The relationship between myasthenia gravis (MG) and cognitive dysfunction has been a matter of debate because of the possible association between peripheral and central nervous system (CNS) cholinergic dysfunction. The aim of this study was to evaluate cognitive function in a series of elderly MG patients in comparison to matched controls. In all, 100 consecutive MG patients aged over 60 years and 31 matched control subjects underwent an extensive neuropsychological test battery to explore multiple cognitive domains. There were no differences in cognitive performances between patients and controls. Severe MG was associated with impaired attention, constructional praxis, and frontal control. Logistic regression analysis showed that advanced age, diabetes, and thyroid dysfunction were independently associated with cognitive impairment. This study does not support the hypothesis of CNS cholinergic involvement in MG. The impairments of attention, memory, and control tasks in MG are related to general visual motor slowness and to the concomitant presence of other diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768771     DOI: 10.1002/mus.21478

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

Review 2.  Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis.

Authors:  Zhifeng Mao; Junjie Yin; Zhengqi Lu; Xueqiang Hu
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

3.  Structural and functional brain alterations in patients with myasthenia gravis.

Authors:  Benita Klaus; Patrick Müller; Nora van Wickeren; Milos Dordevic; Marlen Schmicker; Yael Zdunczyk; Tanja Brigadski; Volkmar Leßmann; Stefan Vielhaber; Stefanie Schreiber; Notger G Müller
Journal:  Brain Commun       Date:  2022-02-01

4.  Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.

Authors:  Antonia Kaltsatou; Dimitris Fotiou; Dimitris Tsiptsios; Anastasios Orologas
Journal:  BBA Clin       Date:  2015-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.